Interactive Session:
117. Interactive Cases in Transplant ID
Friday, October 9, 2015: 10:30 AM-12:00 PM
Room: 20--ABCD

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the clinical presentation of common opportunistic pathogens in transplant patients
  • explain the limitations of culture-based diagnostic tests in immunocompromised transplant patients
  • discuss the differential diagnosis of pulmonary infiltrates in the transplant recipient

Target Audience: Researchers, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Infectious diseases physicians, Fellows, Clinicians

Tracks: Adult ID, Trainee

Interactive Moderator:  David R. Snydman, MD, FIDSA, Tufts Medical Center

Interactive Panelists:  Sanjay Mehta, MD, University of California, San Diego , Maggie Green, MD, Fred Hutchinson Cancer Research Center , Lynne Strasfeld, MD, Oregon Health and Science University and Stan Deresinski, MD, FIDSA, Stanford University

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: No CPE credit is offered for this session

ACPE Number:

Disclosures:

D. R. Snydman, Chimerix: Consultant , Consulting fee
Merck: Scientific Advisor , Consulting fee
Cubist: Grant Investigator and Speaker's Bureau , Research grant , Research support and Speaker honorarium
Tetraphase: Grant Investigator , Grant recipient
Summit: Grant Investigator and Scientific Advisor , Consulting fee and Grant recipient
Actelion: Grant Investigator , Grant recipient
Microbiotix: Scientific Advisor , Consulting fee
Analysis Group: Consultant , Consulting fee
Millenium: Data Safety Monitoring Board , Consulting fee

S. Mehta, None

M. Green, Merck: Research Contractor , Research support
Astellas: Research Contractor and Scientific Advisor , Consulting fee and Research support

L. Strasfeld, None

S. Deresinski, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.